Stories

The business of eliminating gun violence

By Tracy Brawley June 28, 2017

The final installment of the OHSU-PSU Gun Violence as a Public Health Issue forum series explored the role of the business, government and community in helping curb gun violence.

U.S. News & World Report ranks OHSU Doernbecher among the nation’s best children’s hospitals

By Tracy Brawley June 27, 2017

OHSU Doernbecher Children’s Hospital named among the best children’s hospitals in the United States by U.S. News & World Report.

OHSU Knight Cancer Institute and Pacific Northwest National Laboratory team up to focus on a complex form of leukemia

By Amanda Gibbs June 27, 2017

The Office of Cancer Clinical Proteomics Research (OCCPR) at the National Cancer Institute (NCI) announced the institutes that will comprise the Proteogenomic Translational Research Centers, a group created to collaborate with NCI-sponsored clinical trials.

Quality medical care should be a given, no matter a patient's sexual or gender identity

By Holly Hinson June 26, 2017

Cultural competency education can address disparities in treatment for LGBTQI patients, and help providers meet their health care needs.

OHSU opposes Better Health Care Reconciliation Act

June 26, 2017

After review, OHSU is opposed to the U.S. Senate’s Better Health Care Reconciliation Act and believes it offers no significant improvements over the bill passed in the House earlier this year.

Technology expert joins the OHSU Knight Cancer Institute’s center for cancer early detection

By Amanda Gibbs June 22, 2017

Today the OHSU Knight Cancer Institute announced that internationally renowned bioengineering and technology expert Mike Heller, Ph.D., will join the institute’s Cancer Early Detection Advanced Research Center, or CEDAR, to lead its technology efforts.

Study finds nearly half of female cancer survivors experience symptoms of nerve damage, experience more falls well after treatment

By Amanda Gibbs June 19, 2017

A study of more than 500 cancer survivors found that many years after completing treatment, nearly half of women cancer survivors continued to experience chemotherapy-induced peripheral neuropathy, CIPN.

Tackling a life-long medical journey inch by NICH